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Electrophoresis. Western blotting and immunostaining with antibodies specific for histone H4 acetylated at lysines 5, 8, 12, or 16, were used to 
define patterns of H4 acetylation in cell lines from humans (HL60) and the fruit fly Drosophila (S2, Kc). In human cells, the mono-acetylated isoform 
H4Ac, is acetylated predominantly at just one of the four possible lysine residues, lysine 16. This is the first step in the progressive acetylation 
of H4. In contrast, in Drosophila, H4Ac, is acetylatcd at lysines 5, 8, or 12 with approximately equal frequency. Fundamental differences appear 
to exist in control of H4 acetylation in different species, despite the evolutionary conservation of acetylation sites. 
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1. INTRODUCTION 
In all animal species examined so far, 4 lysines in the 
amino-terminal domain of histone H4 are subject to 
cyclical, enzyme-catalyzed, acetylation and deacetyla- 
tion, the net result of which is that each one has its own 
characteristic, steady-state level of acetylation. Changes 
in histone acetylation are associated with changes in the 
transcription, replication and packaging of DNA and 
this modification may play a central role in the control 
of chromatin function (reviewed in [1,2]). 
In the few species studied so far, lysines appear to be 
acetylated in a fixed order. For example, in cuttlefish 
testis the mono-acetylated isoform H4Acl is acetylated 
exclusively at lysine 12, with the more acetylated 
isoforms being generated by addition of acetate groups 
to lysines 5, 16 and 8 in strict sequence [3]. In humans 
and other mammals the situation is rather different. 
Acetylation at a single site, lysine 16, predominates in 
H4Acl, but thereafter site usage is more flexible, with 
isoforms H4Acz and H4Ac3 containing a mixture of 
molecules acetylated at lysine 16 and lysines 8, 12 and 5 
[4,51- 
We have recently prepared a panel of antisera which 
can distinguish H4 molecules acetylated at different 
lysine residues [4,6]. These antibodies are being used to 
test the hypothesis that acetylation at each lysinc has 
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specific effects on chromatin structure and function. 
An approach which is proving particularly valuable to 
this end is to use site-specific antisera to immunolabel 
the giant polytene chromosomes found in some insect 
cells [7]. By this means it is possible to define both the 
distribution of acetylated H4 through the interphase 
genome and its association with functionally different 
chromatin types. However, in order to interpret such 
experiments, it is important to know both the steady- 
state level of H4 acetylation in the species under study 
and the frequency with which different lysine residues 
are acetylated. For this reason we have investigated the 
use of H4 acetylation sites in cells from the fruit fly 
Drosophila using a new approach based on elec- 
trophoresis in acid/urea/Triton gels, Western blotting 
and immunolabelling. 
2. MATERIALS AND METHODS 
2. I a Antisera 
Rabbit untiscra against H4 acetylated at specific lysincs were 
prepared by immunization with synthetic pcptides and characterized 
as described prcviuusly [4,6]. Antisera arc numbered so as 10 define 
both the source of the serum and the specificity. Thus, antiserum 
R6/5 is from rabbit 6 and recognizes H4 molecules acetylated UI lyshc 
5. 
2.2. Cells arrd tissues 
Drosophila cltlbryo cell lines S2 and Kc [S] wcrc obtained from l3r 
W.C.F. Whitfield (CRC Eukaryotic Molecular Gcnctica Research 
Group, Unlvcrsity of Dundcc, UK) and grown at 24*C in Schneider’s 
Drosophila medium supplcmemcd with Wo foetal calf serum, 
pcnicillln, and strcptolnycin (all from Gibco). The humen prolnyeloid 
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cell line HL60 [9] was grown at 37°C in RPM1 1640 medium, 10% 
foetal calf serum, penicillin and streptomycin, in 5% CO2 in air. 
Histone hyperacetylation was induced by growth for 4-16 h in 
medium supplemented with S-10 mM sodium butyrate [lO,l I]. 
2.3. Histone exlruction, electrophoresis and Western blotting 
Histones were extracted from nuclear pellets with 0.2 N HCI as 
described previously 161. Sodium butyrate (2 mM) was present 
throughout the preparation. Electrophoresis on acid/urca/Triton gels 
[12], transfer to nitrocellulose filters [13]. immunolabelling with site- 
specific and ‘L51-conjugated anti-rabbit antibodies and preparation of 
autoradiographs. were carried out as previously described [4]. As 
before, we attempted to ensure complete specificity of antibody 
labelling by including in the labelling mixture for each antibody, the 
three synthetic peptides (l-2 pg/ml) corresponding to the three sites 
not recognized by that antibody. Gels stained with Coomassie blue 
and autoradiographs were scanned and integrated on an LKB 
Ultrascan laser densitometer. 
2.4. Cakulation of frequencies of acetylation at each lysine residue 
The final value for the labelling of each isoform transferred from 
acid/urea/Triton gels with a given antibody depends on (1) the pro- 
tein content of the gel band representing that isoform, (2) the extent 
to which the lysine residue recognized by the antibody is acetylated in 
that isoform (which is what we are trying to calculate). and (3) ex- 
perimental factors, such as the concentration of antibody used for 
labelling and the length of time for which the film is exposed in 
preparing the autoradiographs. 
To calculate the extent to which each lysine residue is acetylated in 
each isoform, antibody binding to each isoform (ax”, where x defines 
the specificity of the antiserum for lysine 5,8. 12, or 16 and n defines 
the isoform, l-4) is first divided by the amount of protein in that 
isoform (p”). The antibody binding per unit of protein for each 
isoform (ax,/p,) is then expressed as a proportion of the value for the 
tetra-actylated isoform, i.e. (axn/pn)/(axJpa). This sets the binding 
per unit of protein to H4Acr to lOO%, which is what it should be, 
given that each site must be fully acetylated in this isoform. Express- 
ing the values as a proportion of H4AcJ also serves to eliminate varia- 
tion from one antibody to another due to experimental factors (3 
above). Ideally, these two operations should give an accurate estimate 
of the percentage acetylation of each of the four sites in each isoform. 
In practice, however, two technical factors influence these values. 
The first is that the protein content of the tetra-acetylated isoform 
can be overestimated due to co-migation of non-H4 proteins. (A good 
example is seen in Fig. IC.) The effect of this is that values for an- 
tibody binding per unit of protein to H4Aca tend to be too low and 
values for other isoforms expressed as a proportion of this therefore 
too high. This manifests itself as occasional values over 100%. This 
is not a serious problem and does not effect the relative level of 
acetylation at each site for a given isoform. Its effects can be minimis- 
ed by adjusting the % acetylation at each site for each isoform by a 
common factor, so that values for H4Acl, H4Acr and H4Ac3 add up 
to 100, 200 and 3OO%, respectively. 
The second problem derives from the inefficient binding of an- 
tibody R12/8 to tetra-acetylated H4. We have shown previously that 
binding of this antibody to acetylated lysine 8 is inhibited by acetyla- 
tion of one or both of the adjacent lysines 141. As a result, binding of 
RI218 to H4Ac4 will be reduced by an unknown factor. We have 
allowed for this in calculating the final results by taking binding to 
H4Ac2 or H4Ac3 (whichever is higher) as 100% for R12/8, rather 
than binding to H4Acd. Because of this, values for acctylation at 
lysinc 8 will always bc maximum cstimatcs. 
3. RESULTS 
Histones were prepared in parallel from the 
Drosophila cell lint S2 and from human HL60 cells, 
either untreated or grown overnight in the presence of 
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sodium butyrate to inhibit histone deacetylation. 
Histones were resolved by electrophoresis on 
acid/urea/Triton ge:s, transferred to nitrocellulose 
filters and immunostained with antisera capable of 
distinguishing between H4 molecules acetylated at each 
of the four lysine residues. Scans of Coomassie blue- 
stained gels and autoradiographs from a representative 
experiment are shown in Fig. 1. 
It is apparent from the Coomassie blue-stained tracks 
(Fig. IA-D) that the steady-state level of H4 acetylation 
is less in Drosophila than in human HL60 cells (com- 
pare panels A and C). Scanning and integration of the 
appropriate peaks showed that 40% of HL60 H4 
molecules contain one or more acetates, whereas only 
18% of S2 H4 is acetylated. Sodium butyrate increased 
H4 acetylation in Drosophila cells, as it does in most 
other species, but the effect was less dramatic than in 
human cells (compare panels B and D). Increasing the 
level of butyrate (to 40 mM) or substituting propionate 
or valerate, both effective deacetylase inhibitors [l I] 
did not increase the effect. We conclude that either 
histone acetate groups turn over more slowly in 
Drosophila cells than in human, or a sub-population of 
Drosophila deacetylases is resistant to inhibition by 
short chain fatty acids. 
Scans from autoradiographs prepared from 52 and 
HL60 histones labelled with site-specific antisera are 
shown in Fig. lE-L. All results shown are from the 
same experiment in which Drosophila and human 
histones were run on adjacent tracks and transferred 
and immunolabelled together. There are clear dif- 
Fig. 1. Scans of histones separated on acid/urea/Triton gels and 
stained with Coomassie blue (panels A-D) or transferred to 
nitrocellulose and immunolabelled with antisera to acetylated H4 
(panels E-L). A,B and E-H: Histones from human HL60cells treated 
overnight with butyrate (B, E-H), or untreated (A). C,D and I-L: 
Histoncs from Drosophila S2 cells treated overnight with butyratc (D, 
I-L) or untreated (C). Tracks containing S2 or HL60 histoncs and 
labellcd with the same antiserum (R6/5, R12/8, R20/I2 or Rl4/16) 
have been placed one above the other and corresponding peaks align- 
ed (dotted lines). These antisera recognize only the acerylated 
isoforms, The number of acetate groups in each H4 isoform is in- 
dicatcd in panel B. Vertical lines define the peaks used for integration. 
In one cast (panel L) a combinution of hlgh background and weak 
labclling made it ncccssary to change the baseline to avoid distortion 
of peak arcas. The baseline used for integration is shown. 
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Fig. 2. Frequency of acetylation at lysines 5,8, 12 and 16 in the mono- 
di-, tri- and tetra-acetylatcd isoforms of H4 from human HL60 cells 
{A) and DrosopMu S2 cells (B). The four vertical bars for each 
isoform show the frequency of acetylation at each of the four sites (5 
to 16, left to right as indicated in panel B). 
ferences between the labelling patterns of histones from 
the two species. Most strikingly, antisera R12/8 and 
R20/12 labelled the mono-acetylated isoform weakly in 
human H4 (panels F and G) but relatively strongly in 
Drosophila (panels J and K). In the scans shown in Fig. 
1, the y axes are set so that the maximum peak height 
for each scan is the same and they therefore cannot be 
used to compare the strength of labelling with different 
antibodies. This can of course be done after integration 
of peaks or simply by inspection of the original 
autoradiographs (not shown). In fact, the antisera 
labelled human and Drosopl~ilu H4 with similar inten- 
sities, although with Iabelling differently distributed 
among the isoforms, with the exception of R14/16 
which labelled Drosophila H4 comparatively weakly. 
The extent to which each lysine residue is acetylated 
in each H4 isoform was calculated as outlined in section 
2. The results are presented in Fig. 2. In HLGO cells, 
H4Ac1 was acetylated predominantly at lysine 16, and 
H4Acz at lysines 16, 8 and, to a lesser extent, 12. These 
findings are generally consistent with previous results 
obtained by both immunolabelling and sequencing 
[4,5]. In contrast, in Drosophila S2 cells, H4Acl was 
acetylated at lysines 12, 8 and 5 in roughly equal pro- 
portions, with acetylation at 16 lower but still signifi- 
cant. Acetylation at each site increased in H4Acz, with 
acetylation at lysine 16 remaining relatively low. Similar 
experiments have been carried out with the in- 
dependently derived Drosophila cell line Kc [8] and 
have shown that, in these cells too, H4Acl is a mixture 
of molecules acetylated at all four sites, with acetylation 
at lysines 8 and 12 occurring mot* frequently. 
Calculation of the frequency of acctylatidn at each 
lysine residue can only be carried out if sufficient tetra- 
acetylated H4 is present to give a measurable signal with 
each antibody. This can only be achieved by treating the 
cells with butyrate, which has the potential disadvan- 
tage that the inhibitor may distort the normal pattern of 
H4 acetylation. To test this, we have compared the bin- 
ding per unit of protein of each antibody to the mono- 
and di-acetylated isoforms from butyrate-treated and 
untreated cells. If butyrate treatment causes a shift in 
the way individual sites are used, then differences in an- 
tibody binding should occur. As shown in Table I, 
within each cell type the values are generally very 
similar, bearing in mind the wide range of variation 
possible, and not consistent with a major, butyrate- 
induced shift in the pattern of site usage. The small ef- 
fect of butyrate treatment on site usage also shows that 
acetylation at each site in H4Acl arises predominantly 
by direct acetylation (i.e. ACO -+ ACI) rather than by 
deacetylation of H4Acz (i.e. via the indirect pathway 
Ace + AC, -+ Act --) Acl’), which would be blocked by 
butyrate. 
Table I 
Antibody binding to the mono-acetylated (1) or di-acctylated (2) isoforma of histone H4 from Drosophila 52 and 
human HL60 cells, either treated with sodium butyrate (+) or untreated (- ) 
Antibody Site detected Antibody bindingiunit protein 
Drosophila S2 Human HL60 
I+ I- I + (‘1 I- 2+ 2- 
R6/5 lysinc 5 11.2 9.8 0.8 0.8 17.0 14.0 
R12/8 lysinc 8 9.6 15.7 I.1 2.3 17.5 18.4 
R20/12 lysinc 12 4,o 2.9 0.8 3.1 10.8 18.1 
R14/16 lysinc 16 II.4 7.1 6.9 908 14.0 12.4 
“‘Binding of antiscrn R6/5, RI218 and R2O/lt to this isoform was very low (xc Fig. 1) and the values given tnus~ 
bc rcgardcd as approximate. 
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We have carried out some experiments to determine 
whether the pattern of site usage found in cultured cells 
from Drosophila embryos is also found in the larval 
salivary glands used for immunofluorescence studies. 
The experimental results obtained so far suggest hat it 
is, though we have been unable to carry out a complete, 
quantitative analysis of site usage due to the difficulty 
of inducing high levels of H4 acetylation in salivary 
glands. However, antisera to H4 acetylated at Iysines 5, 
8, or 12 all labelled the mono- and di-acetylated 
isoforms of H4 from salivary glands, whereas labelling 
was very weak with antibodies to H4 acetylated at lysine 
16. 
4. DISCUSSION 
In humans and other mammals [4,5], cuttIefish [3] 
and tetrahymena [ 141, a single, specific lysine residue is 
the exclusive or predominant site of acetylation in the 
mono-acetylated H4 isoform (H4Acl). The results 
presented here confirm these findings by showing that 
in human HL60 cells H4Acl is acetylated predominant- 
ly at lysine 16. In contrast, in Drosophila cells tested in 
parallel, this isoform is acetylated at lysines 5, 8, or 12 
with approximately equal probability and less so at 
lysine 16. This indicates fundamental differences be- 
tween these species in the control of H4 acetylation. 
Initial acetylation at a single, defined lysine residue 
could be due either to the site specificity of the histone 
acetylase which attaches the first acetate group, or to 
better accessibility of a particular lysine residue, leading 
to preferential acetylation by a relatively non-specific 
enzyme. The fact that lysine 16 is the first residue to be 
acetylated in mammalian cells argues against the latter 
explanation. This residue is closely adjacent to core 
DNA [15] and is likely to be the least accessible of the 
four acetylation sites. Also, to explain the fact that the 
first site to be acetyIated differs between species on the 
basis of accessibility differences, would require fun- 
damental differences in chromatin conformation. 
Thus, catalysis of the first acetylation step by site- 
specific acetylases provides the most likely explanation 
for the observed results, which subsequent acetylation 
steps depending on enzymes which act preferentially on 
H4 molecules acetylated at the first site. 
If the heterogeneous pattern of H4Acl acetylation in 
Drosophila cells is to be explained by site-specific 
acetylases, then there must be different enzymes acting 
on different lysines and presumably located in different 
parts of the genome. (Limited distribution of these en- 
zymes, with large areas of chromatin not subject to 
their activity, could explain the weak response to 
sodium butyrate found in Drosophila cells.) Alter- 
natively, acetylation by a single enzyme with low site 
specificity but limited by the accessibility of the four 
lysines, is also consistent with the results obtained, par- 
ticularly the fact that lysine 16, probably the least ac- 
cessible, is relatively under-used. The former explana- 
tion predicts that H4 molecules acetylated at different 
lysines will show different patterns of distribution 
through the interphase genome, whereas the latter 
predicts no such differences. Immunolabelling ex- 
periments with polytene chromosomes are in progress 
to test these predictions. 
Acknowledgemetm: We thank Dr A. Birley for providing Drosophila 
larvae and the Wellcome Trust and the UK Cancer Research Cam- 
paign for financial support. 
REFERENCES 
[II 
PI 
131 
141 
[51 
t61 
[71 
PI 
VI 
[lOI 
[Ill 
1121 
1131 
[IJI 
iI51 
Csordas. 4. (1990) Biochem. J. 265, 23-38. 
Turner, B.M. (1991) J. Cell Sci. 99, in press. 
Couppez, M., Martin-Ponthieu, A. and Sautiere, P. (1987) J. 
Biol. Chem. 262, 2854-2860. 
Turner, B.M., O’Neill, L.P. and Allan, I.M. (1989) FEES Lett. 
253, 141-145. 
Thorne, A.W., Kmiciek, D.. Mitchelson, K., Sautiere, P. and 
Crane-Robinson, C. (1990) Eur. J. Biochem. 193, 701-703. 
Turner, B.M. and Fellows, G. (1989) Eur. J. Biochem. 179, 
131-139. 
Turner, B.M., Franchi, L. and Wallace, H. (1990) J. Cell Sci. 
96, 335-346. 
Schneider, 1. and Blumenthal, A.B. (1978) in: The Genetics and 
Biology of Drosophila, Vol. 2a, (M. Ashburner and T.R.F. 
Wright, eds.) pp. 265-315, Academic Press, London. 
Collins, S.J. (1987) Blood 70, 1233-1244. 
Candido, E.P., Reeves, R. and Davie, J.R. (1978) Cell 14, 
105-113. 
Scaly, L. and Chalkley, R. (1978) Cell 14, 115-121. 
Alfageme, C.R., Zweidler. A., Mahowald, A. and Cohen, L.H. 
(1974) J. Biol. Chem. 249, 3729-3736. 
Towbin, H., Staehelin, T. and Gordon, J. (1979) Proc. Natl. 
Acad. Sci. USA 76, 4350-4354. 
Chicoine, L.C., Schulman, I.G., Richman, R., Cook, R.G. and 
Allis, C.D. (1986) J. Biol. Chetn. 261, 1071-1076. 
Ebralidse, K.K., Grachcv, S.A. and Mirzabekov, A.D. (1988) 
Nature 331, 365-367. 
248 
